ACAD
17.89
-1.47
-7.59%
AEMD
4.57
-0.33
-6.73%
APRI
1.144
-0.026
-2.1880%
ARNA
1.51
-0.06
-3.82%
ATEC
0.395
-0.005
-1.250%
CNAT
1.69
-0.15
-8.15%
CRXM
0.25
0.00
0.00%
CYTX
0.14
-0.039
-21.8192%
DXCM
52.05
-9.93
-16.02%
GNMK
5.1
+0.02
+0.39%
HALO
7.35
-0.55
-6.9608%
ILMN
136.69
+0.64
+0.47%
INNV
0.035
-0.003
-7.652%
INO
5.885
-0.125
-2.080%
ISCO
2.75
+0.35
+14.58%
ISIS
57.56
0.00
0.00%
LGND
89.17
-3.33
-3.60%
LPTN
0.159
-0.001
-0.8744%
MBVX
0.55
+0.01
+1.8333%
MEIP
1.19
-0.05
-4.0403%
MNOV
4.09
-0.06
-1.45%
MRTX
18.915
-1.345
-6.639%
MSTX
0.415
+0.005
+1.2204%
NBIX
32.75
-3.24
-9.00%
NUVA
40.995
-0.455
-1.098%
ONCS
1.53
-0.16
-9.47%
ONVO
1.99
-0.1
-4.78%
OREX
1.745
-0.095
-5.163%
OTIC
12.82
-0.98
-7.10%
QDEL
16.11
-0.29
-1.77%
RCPT
231.96
0.00
0.00%
RGLS
5.49
-0.45
-7.58%
RMD
56.99
-0.43
-0.75%
SCIE
0.001
0.00
-20.0000%
SPHS
1.654
-0.026
-1.5357%
SRNE
4.91
-0.14
-2.77%
TROV
3.541
-0.309
-8.026%
VICL
0.339
+0.007
+1.9537%
VOLC
18
0.00
0.00%
ZGNX
8.36
-0.13
-1.53%
ACAD
17.89
-1.47
-7.59%
AEMD
4.57
-0.33
-6.73%
APRI
1.144
-0.026
-2.1880%
ARNA
1.51
-0.06
-3.82%
ATEC
0.395
-0.005
-1.250%
CNAT
1.69
-0.15
-8.15%
CRXM
0.25
0.00
0.00%
CYTX
0.14
-0.039
-21.8192%
DXCM
52.05
-9.93
-16.02%
GNMK
5.1
+0.02
+0.39%
HALO
7.35
-0.55
-6.9608%
ILMN
136.69
+0.64
+0.47%
INNV
0.035
-0.003
-7.652%
INO
5.885
-0.125
-2.080%
ISCO
2.75
+0.35
+14.58%
ISIS
57.56
0.00
0.00%
LGND
89.17
-3.33
-3.60%
LPTN
0.159
-0.001
-0.8744%
MBVX
0.55
+0.01
+1.8333%
MEIP
1.19
-0.05
-4.0403%
MNOV
4.09
-0.06
-1.45%
MRTX
18.915
-1.345
-6.639%
MSTX
0.415
+0.005
+1.2204%
NBIX
32.75
-3.24
-9.00%
NUVA
40.995
-0.455
-1.098%
ONCS
1.53
-0.16
-9.47%
ONVO
1.99
-0.1
-4.78%
OREX
1.745
-0.095
-5.163%
OTIC
12.82
-0.98
-7.10%
QDEL
16.11
-0.29
-1.77%
RCPT
231.96
0.00
0.00%
RGLS
5.49
-0.45
-7.58%
RMD
56.99
-0.43
-0.75%
SCIE
0.001
0.00
-20.0000%
SPHS
1.654
-0.026
-1.5357%
SRNE
4.91
-0.14
-2.77%
TROV
3.541
-0.309
-8.026%
VICL
0.339
+0.007
+1.9537%
VOLC
18
0.00
0.00%
ZGNX
8.36
-0.13
-1.53%

Headline »

January 20, 2016 – 9:10 pm

The San Diego Biotechnology Network’s LinkedIn group now has 10,000 members! In our 7+ years, we’ve helped thousands of you meet, find jobs, and make the connections that help our life science hub thrive. Join …

Read the full story »

Breaking San Diego Biotech News

Still Connected After all These Years

February 4, 2016 – 7:00 am

“I don’t really understand how people who have been active in the university can retire,” said William Fenical, UC San Diego distinguished professor of oceanography and director of the Center for Marine Biotechnology and Biomedicine at Scripps Institution of Oceanography. “We’ve dedicated every waking moment of our lives for 50 years to doing things that are beneficial for folks. How do you just drop that?” At 74, Fenical is still is a full-time professor and still researching drugs from the sea, including compounds that look very promising to fight melanoma, multiple myeloma as well as breast and ovarian cancer.

Citizen Scientists Dive in to Support Scripps Exploration on the High Seas

February 4, 2016 – 7:00 am

Scripps Institution of Oceanography’s fleet of research vessels, soon to be augmented with the arrival of the new R/V Sally Ride, has logged hundreds of thousands of nautical miles exploring the world’s oceans—over undersea volcanoes and through monstrous waves—seeking answers to some of the planet’s most daunting environmental challenges.

Improving Odds for Women in Tech? Take Notes from Biotech

February 4, 2016 – 6:59 am

At our entrepreneurial support organization, the Council for Entrepreneurial Development (CED), we often joke about adhering to the proper dress and catering code for our networking events: jeans and…

[[Click headline to continue reading.]]

Blood Simple? Grail’s Cancer Screening Quest Faces Tough Questions

February 4, 2016 – 4:30 am

[Corrected, 2/4/16, 2:05pm. See below.] Three weeks ago the world’s biggest genomic sequencing company, Illumina (NASDAQ: ILMN), unveiled a spinout called Grail to make blood tests that could…

[[Click headline to continue reading.]]


See All News>>

Newest San Diego Biotech Jobs

Assistant Production Planner — Fill Finish — 2nd Shift (3:00-11:00pm) (San Diego)

Let’s Make Things Happen!
Ajinomoto Althea, Inc. is a fully integrated contract development and manufacturing organization providing clinical drug process development and manufacturing services to global biotechnology and pharmaceutical companies.
[…

Microbiology Lab Technician (San Diego)

Summary:
Lab Technician assists QA and R&D Team in daily analytical, sensory and microbiological testing procedures and follows written policies, food safety procedures and metrics to help create consistent products and ingredients.
Essential Dutie […]

Sr. Clinical Research Associate (CRA) – Oncology & Autoimmune Diseases – ACEA Biosciences, Inc. – San Diego, CA

(ACEA) is a privately owned biotechnology company with headquarters in San Diego, California. Home Based or Office Based, Southern California, USA….
From DeviceSpace.com – 08 Feb 2016 18:52:12 GMT
– View all San Diego jobs

Repair Biotech Instruments (Miramar)

For those looking for part time work, disarmingly badass biotech equipment sales startup located off Camino Ruiz in the enchanting business town of Miramar is currently seeking a sexy dragon to shoot arrows, drive forklifts, drink beer, repair extrem […


See All Jobs>>

San Diego Biotech Blog Feed

Trilink: Profiling Pseudouridine

Two New Methods for Sequencing Pseudouridine Leverage Old Chemistry New Methods Reveal ‘Rewiring’ of Genetic Code by Post-Transcriptional Pseudouridination Exciting Future for New Analytical Methods for Modified mRNA Be Sure to Read the Very End of the Blog for a … Continue reading → The... More...

Su Lab: Over 300,000 annotations have been submitted so far, but we’re not done! Your help is still needed on our open doc sets

On Wednesday, the Mark2Cure development team met with Dr. Hudson Freeze (NGLY1 and CDG expert), Dr. Karen Ho (NGLY1.org’s scientific... More...

Su Lab: Over 300,000 annotations have been submitted so far, but we’re not done! Your help is still needed on our open doc sets

On Wednesday, the Mark2Cure development team met with Dr. Hudson Freeze (NGLY1 and CDG expert), Dr. Karen Ho (NGLY1.org’s scientific... More...

Neuwrite SD: Altruism: A Story of Amygdalae and Kidneys

So, how do you begin to study the neural underpinnings of something so difficult to define or identify? And since virtually all of us do kind things on occasion, how would one compare altruists and non-altruists to see whether there are any difference...